Psychological impact of genetic counseling for familial cancer: A systematic review and meta-analysis

Journal of the National Cancer Institute

Volumn 96, Issue 2, 2004, Pages 122-133

  Braithwaite, Dejana ^a   Emery, Jon ^a   Walter, Fiona ^a   Prevost, A Toby ^a   Sutton, Stephen ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ANXIETY; BREAST CANCER; CANCER GENETICS; CANCER RISK; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA BASE; DEPRESSION; EMOTIONAL STRESS; EVIDENCE BASED MEDICINE; FAMILIAL CANCER; FOLLOW UP; GENETIC ANALYSIS; GENETIC COUNSELING; HUMAN; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; MEDICAL LITERATURE; META ANALYSIS; METHODOLOGY; OUTCOMES RESEARCH; OVARY CANCER; PATIENT ATTITUDE; PATIENT EDUCATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK ASSESSMENT;

EID: 1042268918     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/djh017     Document Type: Review

References (75)

1. Ford D. Easton DF, Peto J. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 1995;57:1457-62.
2. Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997;336:1401-8.
3. Lynch HT, de la Chapelle A. Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet 1999;36:801-18.
4. Aarnio M, Sankila R, Pukkala E, Salovaara R, Aaltonen LA, de la Chapelle A, et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 1999;81:214-8.
5. Kinmonth AL, Reinhard J, Bobrow M, Pauker S. The new genetics. Implications for clinical services in Britain and the United States. BMJ 1998;316:767-70.
6. Collins FS, Guttmacher AE. Genetics moves into the medical mainstream. JAMA 2001;286:2322-4.
7. Clarke A, Parsons E, Williams A. Outcomes and process in genetic counselling. Clin Genet 1996;50:462-9.
8. Bowles Biesecker B, Marteau TM. The future of genetic counselling: an international perspective. Nat Genet 1999;22:133-7.
9. Meiser B, Halliday JL. What is the impact of genetic counselling in women at increased risk of developing hereditary breast cancer? A meta-analytic review. Soc Sci Med 2002;54:1463-70.
10. Audrain J, Rimer B, Cella D, Stefanek M, Garber J, Pennanen M, et al. The impact of a brief coping skills intervention on adherence to breast self-examination among first-degree relatives of newly diagnosed breast cancer patients. Psychooncology 1999;8:220-9.
11. Brain K, Gray J, Norman P, France E, Anglim C, Barton G, et al. Randomized trial of a specialist genetic assessment service for familial breast cancer. J Natl Cancer Inst 2000;92:1345-51.
12. Lerman C, Lustbader E, Rimer B, Daly M, Miller S, Sands C, et al. Effects of individualized breast cancer risk counseling: a randomized trial. J Natl Cancer Inst 1995;87:286-92.
13. Lerman C, Schwartz MD, Miller SM, Daly M, Sands C, Rimer BK. A randomized trial of breast cancer risk counseling: interacting effects of counseling, educational level, and coping style. Health Psychol 1996;15: 75-83.
14. Lerman C, Biesecker B, Benkendorf JL, Kerner J, Gomez-Caminero A, Hughes C, et al. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. J Natl Cancer Inst 1997;89:148-57.
15. Randall J, Butow P, Kirk J, Tucker K. Psychological impact of genetic counselling and testing in women previously diagnosed with breast cancer. Intern Med J 2001;31:397-405.
16. Schwartz MD, Lerman C, Audrain J, Cella D, Rimer B, Stefanek M, et al. The impact of a brief problem-solving training intervention for relatives of recently diagnosed breast cancer patients. Ann Behav Med 1998;20:7-12.
17. Schwartz MD, Rimer BK, Daly M, Sands C, Lerman C. A randomised trial of breast cancer risk counselling: the impact on self-reported mammography use. Am J Public Health 1999;89:924-6.
18. Alexander NE, Ross J, Sumner W, Nease RF Jr, Littenberg B. The effect of an educational intervention on the perceived risk of breast cancer. J Gen Intern Med 1996;11:92-7.
19. Bish A, Sutton S, Jacobs C, Levene S, Ramirez A, Hodgson S. Changes in psychological distress after cancer genetic counselling: a comparison of affected and unaffected women. Br J Cancer 2002;86:43-50.
20. Collins V, Halliday J, Warren R, Williamson R. Cancer worries, risk perceptions and associations with interest in DNA testing and clinic satisfaction in a familial colorectal cancer clinic. Clin Genet 2000;58:460-8.
21. Collins V, Halliday J, Warren R, Williamson R. Assessment of education and counselling offered by a familial colorectal cancer clinic. Clin Genet 2000;57:48-55.
22. Cull A, Miller H, Porterfield T, Mackay J, Anderson ED, Steel CM, et al. The use of videotaped information in cancer genetic counselling: a randomized evaluation study. Br J Cancer 1998;77:830-7.
23. Cull A, Anderson ED, Campbell S, Mackay J, Smyth E, Steel M. The impact of genetic counselling about breast cancer risk on womens's risk perceptions and levels of distress. Br J Cancer 1999;79:501-8.
24. Evans DG, Blair V, Greenhalgh R, Hopwood P, Howell A. The impact of genetic counselling on risk perception in women with a family history of breast cancer. Br J Cancer 1994;70:934-8.
25. Gagnon P, Massie MJ, Kash KM, Gronert M, Simkovich Heerdt A, Brown K, et al. Perception of breast cancer risk and psychological distress in women attending a surveillance program. Psychooncology 1996;5:259-69.
26. Hopwood P, Keeling F, Long A, Pool C, Evans G, Howell A. Psychological support needs for women at high genetic risk of breast cancer: some preliminary indicators. Psychooncology 1998;7:402-12.
27. Hopwood P, Shenton A, Lalloo F, Evans DG, Howell A. Risk perception and cancer worry: an exploratory study of the impact of genetic risk counselling in women with a family history of breast cancer. J Med Genet 2001;38:139.
28. Julian-Reynier C, Eisinger F, Chabal F, Aurran Y, Bignon YI, Machelard-Roumagnac M, et al. Cancer genetic consultation and anxiety in healthy consultees. Psychology and Health 1999;14:379-90.
29. Kent G, Howie H, Fletcher M, Newbury-Ecob R, Hosie K. The relationship between perceived risk, thought intrusiveness and emotional well-being in women receiving counselling for breast cancer risk in a family history clinic. Br J Health Psychol 2000;5:15-26.
30. Meiser B, Butow PN, Barratt AL, Schnieden V, Gattas M, Kirk J, et al. Long-term outcomes of genetic counseling in women at increased risk of developing hereditary breast cancer. Patient Educ Couns 2001;44:215-25.
31. Ritvo P, Robinson G, Irvine J, Brown L, Matthew A, Murphy KJ, et al. Psychological adjustment to familial genetic risk assessment: differences in two longitudinal samples. Patient Educ Couns 2000;40:163-72.
32. Sagi M, Kaduri L, Zlotogora J, Peretz T. The effect of genetic counselling on knowledge and perceptions regarding risks for breast cancer. J Genet Counsel 1998;7:417-34.
33. Watson M, Duvivier V, Wade Walsh M, Ashley S, Davidson J, Papaikonomou M, et al. Family history of breast cancer: what do women understand and recall about their genetic risk? J Med Genet 1998;35:731-8.
34. Watson M, Lloyd S, Davidson J, Meyer L, Eeles R, Ebbs S, et al. The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer. Br J Cancer 1999;79:868-74.
35. Hedges LV, Olkin I. Statistical methods for meta-analysis. Orlando (FL): Academic Press; 1985.
36. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
37. Cohen J. Statistical power for the behavioural sciences. 2nd ed. Hillsdale (NJ): Erlbaum; 1988.
38. Yudkin PL, Stratton IM. How to deal with regression to the mean in intervention studies. Lancet 1996;347:241-3.
39. Aktan-Collan K, Haukkala A, Mecklin JP, Uutela A, Kaariainen H. Comprehension of cancer risk one and 12 months after predictive genetic testing for hereditary non-polyposis colorectal cancer. J Med Genet 2001;38:787-92.
40. Audrain J, Schwartz MD, Lerman C, Hughes C, Peshkin BN, Biesecker B. Psychological distress in women seeking genetic counseling for breast-ovarian cancer risk: the contributions of personality and appraisal. Ann Behav Med 1997;19:370-7.
41. Bleiker EM, Aaronson NK, Menko FH, Hahn DE, van Asperen CJ, Rutgers EJ, et al. Genetic counseling for hereditary cancer: a pilot study on experiences of patients and family members. Patient Educ Couns 1997;32: 107-16.
42. Burke W, Culver JO, Bowen D, Lowry D, Durfy S, McTiernan A, et al. Genetic counseling for women with an intermediate family history of breast cancer. Am J Med Genet 2000;90:361-8.
43. Esplen MJ, Toner B, Hunter J, Glendon G, Butler K, Field B. A group therapy approach to facilitate integration of risk information for women at risk for breast cancer. Can J Psychiatry 1998;43:375-80.
44. Hallowell N, Green JM, Statham H, Murton F, Richards MP. Recall of numerical risk estimates and counsellees' perceptions of the importance of risk information following genetic counselling for breast and ovarian cancer. Psychol Health Med 1997;2:149-59.
45. Hallowell N, Statham H, Murton F, Green JM, Richards MP. "Talking about chance": the presentation of risk information during genetic counselling for breast and ovarian cancer. J Genet Counsel 1997;6:269-86.
46. Hallowell N, Statham H, Murton F. Women's understanding of their risk of developing breast/ovarian cancer before and after genetic counselling. J Genet Counsel 1998;7:345-64.
47. Hofferbert S, Worringen U, Backe J, Ruckert EM, White K, Faller H, et al. Simultaneous interdisciplinary counseling in German breast/ovarian cancer families: first experiences with patient perceptions, surveillance behavior and acceptance of genetic testing. Genet Couns 2000;11:127-46.
48. Kash KM, Holland JC, Osborne MP, Miller DG. Psychological counseling strategies for women at risk of breast cancer. J Natl Cancer Inst Monogr 1995:73-9.
49. Lloyd S, Watson M, Waites B, Meyer L, Eeles R, Ebbs S, et al. Familial breast cancer: a controlled study of risk perception, psychological morbidity and health beliefs in women attending for genetic counselling. Br J Cancer 1996;74:482-7.
50. Metcalfe KA, Liede A, Hoodfar E, Scott A, Foulkes WD, Narod SA. An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counselling. J Med Genet 2000;37:866-74.
51. Shoda Y, Mischel W, Miller SM, Diefenbach M, Daly M, Engstrom PF. Psychological interventions and genetic testing: facilitating informed decisions about BRCA1/2 cancer susceptibility. J Clin Psychol Med Settings 1998;5:3-17.
52. Stadler MP, Mulvihill JJ. Cancer risk assessment and genetic counselling in an academic medical center: consultants' satisfaction, knowledge and behavior in the first year. J Genet Couns 1998;7:279-97.
53. Stalmeier PF, Unic IJ, Verhoef LC, Van Daal WA. Evaluation of a shared decision making program for women suspected to have a genetic predisposition to breast cancer: preliminary results. Med Decis Making 1999;19: 230-41.
54. Tercyak KP, Lerman C, Peshkin BN, Hughes C, Main D, Isaacs C, et al. Effects of coping style and BRCA1 and BRCA2 test results on anxiety among women participating in genetic counseling and testing for breast and ovarian cancer risk. Health Psychol 2001;20:217-22.
55. Trask PC, Paterson AG, Wang C, Hayasaka S, Milliron KJ, Blumberg LR, et al. Cancer-specific worry interference in women attending a breast and ovarian cancer risk evaluation program: impact on emotional distress and health functioning. Psychooncology 2001;10:349-60.
56. Wagner TM, Moslinger R, Langbauer G, Ahner R, Fleischmann E, Auterith A, et al. Attitude towards prophylactic surgery and effects of genetic counselling in families with BRCA mutations. Austrian Hereditary Breast and Ovarian Cancer Group. Br J Cancer 2000;82:1249-53.
57. Claus EB, Risch N, Thompson WD. Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 1991;48:232-42.
58. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989;81:1879-86.
59. Horowitz M, Wilner N, Alvarez W. Impact of Event Scale: a measure of subjective stress. Psychosom Med 1979;41:209-19.
60. Kash KM, Holland JC, Halper MS, Miller DG. Psychological distress and surveillance behaviors of women with a family history of breast cancer. J Natl Cancer Inst 1992;84:24-30.
61. Marteau TM, Lerman C. Genetic risk and behavioural change. BMJ 2001; 322:1056-9.
62. Emery J. Is informed choice in genetic testing a different breed of informed decision-making? A discussion paper. Health Expect 2001;4:81-6.
63. Marteau TM, Dormandy E, Michie S. A measure of informed choice. Health Expect 2001;4:99-108.
64. Sutton S. Using theories of behaviour change to develop and evaluate sexual health interventions. In: Stephenson JM, Imrie J, Bonell C, editors. Effective sexual health interventions: issues in experimental evaluation. New York (NY): Oxford University Press; 2003.
65. Campbell M, Fitzpatrick R, Haines A, Kinmonth AL, Sandercock P, Spiegelhalter D, et al. Framework for design and evaluation of complex interventions to improve health. BMJ 2000;321:694-6.
66. Moher D, Schulz KF, Altman D; CONSORT Group; (Consolidated Standards of Reporting Trials. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001;285:1987-91.
67. Spielberger CD. Manual of the State-Trait Anxiety Inventory. Palo Alto (CA): Consulting Psychologists Press; 1983.
68. Marteau TM, Bekker H. The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). Br J Clin Psychol 1992;31:301-6.
69. Goldberg D, Williams P. A user's guide to the general health questionnaire. Windsor (U.K.): NFER-Nelson; 1988.
70. McNair D, Lorr M, Droppelman L. Profile of mood states. San Diego (CA): Educational and Industrial Testing Service; 1971.
71. Beck AT, Steer R. Beck depression inventory manual. San Antonio (TX): Harcourt Brace Jovanovic; 1993.
72. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70.
73. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1997;1:385-401.
74. Lerman C, Trock B, Rimer BK, Jepson C, Brody D, Boyce A. Psychological side effects of breast cancer screening. Health Psychol 1991;10:259-67.
75. Statham H, Green JM, Kafetsios K. Who worries that something might be wrong with the baby? A prospective study of 1072 pregnant women. Birth 1997;24:223-33.